Palifermin and chemotherapy-induced oral mucositis [1] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 12, 2005, Pages 1264-1265

  Awada, Ahmad ^a   Genot, Marie Thérèse ^a   Klastersky, Jean ^a   Köstler, Wolfgang J ^b   Hejna, Michael ^b   Zielinski, Christoph C ^b   Palmieri, Carlo ^c   Vigushin, David ^c   Spielberger, Ricardo ^d   Stiff, Patrick ^e   Bensinger, William ^f  

^a JULES BORDET INSTITUTE   (Belgium)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^e LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PALIFERMIN; FGF7 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DISEASE SEVERITY; DRUG SAFETY; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; LETTER; LOW LEVEL LASER THERAPY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RISK FACTOR; SKIN TOXICITY; BLOOD DISEASE; KERATINOCYTE; MOUTH MUCOSA; NOTE; RADIOTHERAPY; STOMATITIS; METHODOLOGY; STATISTICAL ANALYSIS; CHEMICALLY INDUCED DISORDER; LASER;

ANTINEOPLASTIC AGENTS; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; HEMATOLOGIC NEOPLASMS; HUMANS; KERATINOCYTES; MOUTH MUCOSA; RADIOTHERAPY; STOMATITIS; DATA INTERPRETATION, STATISTICAL; RESEARCH DESIGN; RISK FACTORS; LASERS;

EID: 15944409514     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200503243521219     Document Type: Letter

References (0)